{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:02:53Z","timestamp":1740106973878,"version":"3.37.3"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,4,30]],"date-time":"2018-04-30T00:00:00Z","timestamp":1525046400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s00213-018-4917-5","type":"journal-article","created":{"date-parts":[[2018,4,30]],"date-time":"2018-04-30T03:58:52Z","timestamp":1525060732000},"page":"1835-1844","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Interest of new alkylsulfonylhydrazide-type compound in the treatment of alcohol use disorders"],"prefix":"10.1007","volume":"235","author":[{"given":"J\u00e9r\u00f4me","family":"Jeanblanc","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika","family":"Bourguet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Sketrien\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9line","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gautier","family":"Moroy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u00e9mi","family":"Legastelois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathieu","family":"L\u00e9t\u00e9v\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aur\u00e9lie","family":"Trussardi-R\u00e9gnier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9788-0918","authenticated-orcid":false,"given":"Micka\u00ebl","family":"Naassila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,4,30]]},"reference":[{"key":"4917_CR1","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1016\/S0960-894X(03)00214-2","volume":"13","author":"F Auge","year":"2003","unstructured":"Auge F, Hornebeck W, Decarme M, Laronze JY (2003) Improved gelatinase a selectivity by novel zinc binding groups containing galardin derivatives. Bioorg Med Chem Lett 13:1783\u20131786","journal-title":"Bioorg Med Chem Lett"},{"key":"4917_CR2","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1038\/mp.2016.131","volume":"22","author":"E Barbier","year":"2017","unstructured":"Barbier E, Johnstone AL, Khomtchouk BB, Tapocik JD, Pitcairn C, Rehman F, Augier E, Borich A, Schank JR, Rienas CA, Van Booven DJ, Sun H, Natt D, Wahlestedt C, Heilig M (2017) Dependence-induced increase of alcohol self-administration and compulsive drinking mediated by the histone methyltransferase PRDM2. Mol Psychiatry 22:1746\u20131758","journal-title":"Mol Psychiatry"},{"key":"4917_CR3","first-page":"348","volume":"31","author":"HC Becker","year":"2008","unstructured":"Becker HC (2008) Alcohol dependence, withdrawal, and relapse. Alcohol Res Health 31:348\u2013361","journal-title":"Alcohol Res Health"},{"key":"4917_CR4","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1111\/acer.13338","volume":"41","author":"TD Berkel","year":"2017","unstructured":"Berkel TD, Pandey SC (2017) Emerging role of epigenetic mechanisms in alcohol addiction. Alcohol Clin Exp Res 41:666\u2013680","journal-title":"Alcohol Clin Exp Res"},{"key":"4917_CR5","doi-asserted-by":"publisher","first-page":"e47527","DOI":"10.1371\/journal.pone.0047527","volume":"7","author":"B Botia","year":"2012","unstructured":"Botia B, Legastelois R, Alaux-Cantin S, Naassila M (2012) Expression of ethanol-induced behavioral sensitization is associated with alteration of chromatin remodeling in mice. PLoS One 7:e47527","journal-title":"PLoS One"},{"key":"4917_CR6","doi-asserted-by":"crossref","unstructured":"Bourguet E, Ozdarska K, Moroy G, Jeanblanc J, Naassila M (2018) Class I HDAC inhibitors: potential new epigenetic therapeutics for alcohol use disorder (AUD). J Med Chem\u00a061:1745-1766","DOI":"10.1021\/acs.jmedchem.7b00115"},{"key":"4917_CR7","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.2174\/13895575110091263","volume":"10","author":"AV Chavan","year":"2010","unstructured":"Chavan AV, Somani RR (2010) HDAC inhibitors\u2014new generation of target specific treatment. Mini Rev Med Chem 10:1263\u20131276","journal-title":"Mini Rev Med Chem"},{"key":"4917_CR8","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1042\/bj20021321","volume":"370","author":"AJ Ruijter de","year":"2003","unstructured":"de Ruijter AJ, van Gennip AH, Caron HN, Kemp S, van Kuilenburg AB (2003) Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J 370:737\u2013749","journal-title":"Biochem J"},{"key":"4917_CR9","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.biopsych.2014.09.008","volume":"77","author":"NW Gilpin","year":"2015","unstructured":"Gilpin NW, Herman MA, Roberto M (2015) The central amygdala as an integrative hub for anxiety and alcohol use disorders. Biol Psychiatry 77:859\u2013869","journal-title":"Biol Psychiatry"},{"key":"4917_CR10","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.bbrc.2004.10.082","volume":"325","author":"KB Glaser","year":"2004","unstructured":"Glaser KB, Li J, Pease LJ, Staver MJ, Marcotte PA, Guo J, Frey RR, Garland RB, Heyman HR, Wada CK, Vasudevan A, Michaelides MR, Davidsen SK, Curtin ML (2004) Differential protein acetylation induced by novel histone deacetylase inhibitors. Biochem Biophys Res Commun 325:683\u2013690","journal-title":"Biochem Biophys Res Commun"},{"key":"4917_CR11","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1021\/cn9000268","volume":"1","author":"JM Hooker","year":"2010","unstructured":"Hooker JM, Kim SW, Alexoff D, Xu Y, Shea C, Reid A, Volkow N, Fowler JS (2010) Histone deacetylase inhibitor, MS-275, exhibits poor brain penetration: PK studies of [C]MS-275 using positron emission tomography. ACS Chem Neurosci 1:65\u201373","journal-title":"ACS Chem Neurosci"},{"key":"4917_CR12","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1159\/000449486","volume":"23","author":"A Jangra","year":"2016","unstructured":"Jangra A, Sriram CS, Pandey S, Choubey P, Rajput P, Saroha B, Bezbaruah BK, Lahkar M (2016) Epigenetic modifications, alcoholic brain and potential drug targets. Ann Neurosci 23:246\u2013260","journal-title":"Ann Neurosci"},{"key":"4917_CR13","doi-asserted-by":"publisher","first-page":"pyv029","DOI":"10.1093\/ijnp\/pyv029","volume":"18","author":"J Jeanblanc","year":"2015","unstructured":"Jeanblanc J, Lemoine S, Jeanblanc V, Alaux-Cantin S, Naassila M (2015) The class I-specific HDAC inhibitor MS-275 decreases motivation to consume alcohol and relapse in heavy drinking rats. Int J Neuropsychopharmacol 18:pyv029","journal-title":"Int J Neuropsychopharmacol"},{"key":"4917_CR14","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/nrd2681","volume":"7","author":"AG Kazantsev","year":"2008","unstructured":"Kazantsev AG, Thompson LM (2008) Therapeutic application of histone deacetylase inhibitors for central nervous system disorders. Nat Rev Drug Discov 7:854\u2013868","journal-title":"Nat Rev Drug Discov"},{"key":"4917_CR15","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1042\/BJ20070779","volume":"409","author":"N Khan","year":"2008","unstructured":"Khan N, Jeffers M, Kumar S, Hackett C, Boldog F, Khramtsov N, Qian X, Mills E, Berghs SC, Carey N, Finn PW, Collins LS, Tumber A, Ritchie JW, Jensen PB, Lichenstein HS, Sehested M (2008) Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors. Biochem J 409:581\u2013589","journal-title":"Biochem J"},{"key":"4917_CR16","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1111\/acer.12088","volume":"37","author":"R Legastelois","year":"2013","unstructured":"Legastelois R, Botia B, Naassila M (2013) Blockade of ethanol-induced behavioral sensitization by sodium butyrate: descriptive analysis of gene regulations in the striatum. Alcohol Clin Exp Res 37:1143\u20131153","journal-title":"Alcohol Clin Exp Res"},{"key":"4917_CR17","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1051\/jbio\/2017014","volume":"211","author":"R Legastelois","year":"2017","unstructured":"Legastelois R, Jeanblanc J, Vilpoux C, Bourguet E, Naassila M (2017) Epigenetic mechanisms and alcohol use disorders: a potential therapeutic target. Biol Aujourdhui 211:83\u201391","journal-title":"Biol Aujourdhui"},{"key":"4917_CR18","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.biopsych.2013.01.012","volume":"73","author":"S Moonat","year":"2013","unstructured":"Moonat S, Sakharkar AJ, Zhang H, Tang L, Pandey SC (2013) Aberrant histone deacetylase2-mediated histone modifications and synaptic plasticity in the amygdala predisposes to anxiety and alcoholism. Biol Psychiatry 73:763\u2013773","journal-title":"Biol Psychiatry"},{"key":"4917_CR19","doi-asserted-by":"publisher","first-page":"3729","DOI":"10.1523\/JNEUROSCI.5731-07.2008","volume":"28","author":"SC Pandey","year":"2008","unstructured":"Pandey SC, Ugale R, Zhang H, Tang L, Prakash A (2008) Brain chromatin remodeling: a novel mechanism of alcoholism. J Neurosci 28:3729\u20133737","journal-title":"J Neurosci"},{"key":"4917_CR20","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.neuropharm.2017.02.002","volume":"122","author":"SC Pandey","year":"2017","unstructured":"Pandey SC, Kyzar EJ, Zhang H (2017) Epigenetic basis of the dark side of alcohol addiction. Neuropharmacology 122:74\u201384","journal-title":"Neuropharmacology"},{"key":"4917_CR21","doi-asserted-by":"publisher","first-page":"a012195","DOI":"10.1101\/cshperspect.a012195","volume":"2","author":"M Roberto","year":"2012","unstructured":"Roberto M, Gilpin NW, Siggins GR (2012) The central amygdala and alcohol: role of gamma-aminobutyric acid, glutamate, and neuropeptides. Cold Spring Harb Perspect Med 2:a012195","journal-title":"Cold Spring Harb Perspect Med"},{"key":"4917_CR22","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1530-0277.2011.01581.x","volume":"36","author":"AJ Sakharkar","year":"2012","unstructured":"Sakharkar AJ, Zhang H, Tang L, Shi G, Pandey SC (2012) Histone deacetylases (HDAC)-induced histone modifications in the amygdala: a role in rapid tolerance to the anxiolytic effects of ethanol. Alcohol Clin Exp Res 36:61\u201371","journal-title":"Alcohol Clin Exp Res"},{"key":"4917_CR23","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1017\/S1461145714000054","volume":"17","author":"AJ Sakharkar","year":"2014","unstructured":"Sakharkar AJ, Zhang H, Tang L, Baxstrom K, Shi G, Moonat S, Pandey SC (2014) Effects of histone deacetylase inhibitors on amygdaloid histone acetylation and neuropeptide Y expression: a role in anxiety-like and alcohol-drinking behaviours. Int J Neuropsychopharmacol 17:1207\u20131220","journal-title":"Int J Neuropsychopharmacol"},{"key":"4917_CR24","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.3748\/wjg.15.1219","volume":"15","author":"BD Shepard","year":"2009","unstructured":"Shepard BD, Tuma PL (2009) Alcohol-induced protein hyperacetylation: mechanisms and consequences. World J Gastroenterol 15:1219\u20131230","journal-title":"World J Gastroenterol"},{"key":"4917_CR25","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.alcohol.2009.01.002","volume":"43","author":"Y Silberman","year":"2009","unstructured":"Silberman Y, Bajo M, Chappell AM, Christian DT, Cruz M, Diaz MR, Kash T, Lack AK, Messing RO, Siggins GR, Winder D, Roberto M, McCool BA, Weiner JL (2009) Neurobiological mechanisms contributing to alcohol-stress-anxiety interactions. Alcohol 43:509\u2013519","journal-title":"Alcohol"},{"key":"4917_CR26","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.mehy.2012.09.021","volume":"79","author":"N Simioni","year":"2012","unstructured":"Simioni N, Cottencin O, Guardia D, Rolland B (2012) Early relapse in alcohol dependence may result from late withdrawal symptoms. Med Hypotheses 79:894\u2013895","journal-title":"Med Hypotheses"},{"key":"4917_CR27","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1111\/adb.12161","volume":"20","author":"E Simon-O\u2019Brien","year":"2015","unstructured":"Simon-O\u2019Brien E, Alaux-Cantin S, Warnault V, Buttolo R, Naassila M, Vilpoux C (2015) The histone deacetylase inhibitor sodium butyrate decreases excessive ethanol intake in dependent animals. Addict Biol 20:676\u2013689","journal-title":"Addict Biol"},{"key":"4917_CR28","doi-asserted-by":"publisher","first-page":"e231","DOI":"10.1038\/tp.2013.4","volume":"3","author":"V Warnault","year":"2013","unstructured":"Warnault V, Darcq E, Levine A, Barak S, Ron D (2013) Chromatin remodeling\u2014a novel strategy to control excessive alcohol drinking. Transl Psychiatry 3:e231","journal-title":"Transl Psychiatry"},{"key":"4917_CR29","doi-asserted-by":"crossref","unstructured":"Mottet D, Castronovo V (2008) Histone deacetylases: target enzymes for cancer therapy. Clin Exp Metastasis 25:183\u2013189","DOI":"10.1007\/s10585-007-9131-5"},{"key":"4917_CR30","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-Moreno JA, Marcos M, Calleja-Conde J, Echeverry-Alzate V, B\u00fchler KM, Costa-Alba P, Bernardo E, Laso FJ, de Fonseca FR, Nadal R, Paz Viveros M, Maldonado R, Gin\u00e9 E (2015) Histone deacetylase gene expression following binge alcohol consumption in rats and humans. Alcohol Clin Exp Res 39:1939\u20131950","DOI":"10.1111\/acer.12850"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-018-4917-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-018-4917-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-018-4917-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T09:06:39Z","timestamp":1556615199000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-018-4917-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,30]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["4917"],"URL":"https:\/\/doi.org\/10.1007\/s00213-018-4917-5","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"type":"print","value":"0033-3158"},{"type":"electronic","value":"1432-2072"}],"subject":[],"published":{"date-parts":[[2018,4,30]]},"assertion":[{"value":"19 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Experiments were carried out in accordance with the guidelines for Care and Use of Laboratory Animals (National Institutes of Health) and the European community regulations for animal use in research (CEE no. 86\/609) and were approved by the local research ethics committee (CREMEAP; no. 260912-10).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}}]}}